Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▾	Diluted EPS
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
ARQT	Arcutis Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$372.07M	-$16.14M	-4.3%	-8.5%	123.4%	-$0.13
PTCT	PTC Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.73B	$682.64M	39.4%	n/a	114.5%	$7.78
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
BCYC	Bicycle Therapeutics PLC Manufacturing · Year ended 2025-12-31 · USD	$72.59M	-$218.96M	-301.7%	-35.9%	105.8%	-$3.16
ALT	Altimmune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.0K	-$88.09M	n/m	-39.2%	105.0%	-$1.00
ETON	Eton Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$79.95M	-$4.60M	-5.8%	-17.6%	104.9%	n/a
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22
ELTP	Elite Pharmaceuticals Inc Manufacturing · Year ended 2026-03-31 · USD	$148.87M	$44.87M	30.1%	45.4%	77.1%	$0.03
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
TXMD	TherapeuticsMD, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02M	-$569.0K	-18.8%	-2.1%	71.6%	-$0.05
SLGL	Sol-Gel Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$19.39M	-$6.13M	-31.6%	-26.9%	68.0%	-$2.19
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
INSM	Insmed Inc Manufacturing · Year ended 2025-12-31 · USD	$606.42M	-$1.28B	-210.5%	-172.8%	66.7%	-$6.42
CPMD	Cannapharmarx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.36M	-$11.13M	-817.2%	n/a	66.1%	-$0.02
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
SXTP	60 Degrees Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.01M	-$7.37M	-732.5%	-212.7%	65.5%	-$11.73
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
LGND	Ligand Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$268.09M	$124.45M	46.4%	12.2%	60.4%	$6.13
LXRX	Lexicon Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$49.80M	-$50.34M	-101.1%	-46.8%	60.2%	-$0.14
KNSA	Kiniksa Pharmaceuticals International, plc Manufacturing · Year ended 2025-12-31 · USD	$677.56M	$59.01M	8.7%	10.4%	60.1%	$0.75
RANI	Rani Therapeutics Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.63M	-$40.95M	n/m	-124.1%	58.9%	-$0.45

Rows per page: 2550 100